RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyrias

RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyrias

On July 24, 2018, we hosted an online RNAi Roundtable to review the progress with givosiran, an RNAi therapeutic in development for the treatment of acute hepatic porphyrias.

Access the replay

View the presentation

Read the transcript

  • Akin Akinc, Ph.D., General Manager, Givosiran
  • Jae Kim, M.D., Vice President, Clinical Development
  • Mary, patient living with acute intermittent porphyria




Diese Website ist nur für Einwohner in Deutschland bestimmt.